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Although at the turn of this century and earlier, clinicians 
recognized that renal failure with oliguria was a condition sometimes 
superimposed upon such diverse pathological states as the acute epi¬ 
sodes of Bright's Disease, fulminant cholera, cardiovascular collapse, 
mercury poisoning and surgical procedures, there was little insight 
into the mechanism and morbid implications of this urinary suppression 
(1, 2, 3,). The main attention was directed to the underlying emer¬ 
gency since it was with this that the a-f piloted often and quickly 
succumbed. In the event that the patient survived the first days 
of the initial insult, then the problem of the renal failure became 
a very real one. In the light of our present knowledge that acute 
renal failure, once established, is produced by a variable degree of 
damage to the tubular cells of the kidney, the earliest attempts at 
therapy for the condition seem to us misguided. They consisted in the 
use of diuretics and the forcing of fluids in the attempt to reinstate 
proper kidney function. This form of therapy presumed an intact and 
functioning tubule and eventuated in overhydration, hastening death 
by the production of pulmonary edema. 
The development of modern methods of medical treatment (e.g. intra¬ 
venous replacement therapy, antibiotics) has greatly decreased the 
mortality directly associated with the acute disaster producing renal 
failure. Also to be noted, is that some forms of modern therapy in 
themselves predispose to the development of anuria through tubular 
damage (e.g. injudicious sulfonamide administration, inaccurately 
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clinician today finds himself vis a vis the problem of acute renal 
failure at least as often as were his forebears. However, this com¬ 
plication is no longer considered as dire a threat as it was 60 or 
even 10 years ago. Improved methods of diagnosis have allowed 
better definition of the pathological and biochemical derangements 
in acute tubular necrosis, permitting a more rational and successful 
approach to therapy. 
Inasmuch as the acute renal deficiency involves failure of the 
kidneys for an unpredictable number of days to regulate the water and 
electrolyte equilibrium as well as to excrete the products of cellu¬ 
lar metabolism, the more refined principles to be observed in its 
treatment may be briefly summarized: 
a) Avoidance of excessive salt and water administration. 
b) Suppression of cellular breakdown which results in 
accumulation of acids and potassium in the extra- 
cellular fluid. 
In recent years the necessity for restricting salt and water 
has been extensively dealt with, emphasizing the strict limitation 
of these essentials to cover losses, both obvious and insensible, 
and taking into account endogenous water production (k, 6, 7; 8). 
Attention will be directed here to some approaches aimed at 
the second goal in the therapy of acute renal failure, that of in¬ 
hibiting the accumulation of products of cellular catabolism with 
the resultant toxic effects upon the organism. In the anuric indi¬ 
vidual such products of cellular breakdown as non-protein nitrogen, 
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potassium and the acid metabolites: sulphates, phosphates, and 
urates, as would normally be excreted in the urine, accumulate in 
the extracellular fluid. If the "protein-sparing action" of non¬ 
protein calories is utilized in the form of carbohydrates or fats 
for energy requirements, the oxidation of endogenous protein and 
coincident cellular destruction can be minimized. 
In his starvation experiments on normal human subjects, 
Gamble (9) pointed out that protein breakdown could be markedly re¬ 
duced on an optimal diet of glucose alone. 
In the situation of acute renal failure and the extremely high 
caloric requirements brought about by the stress of antecedent 
trauma, intoxication or infection, and the necessity for drastic 
limitation of the fluid vehicle to be used in the administration 
of calories, several investigators have recommended fat in addition 
to carbohydrate in the therapeutic regimen (10, ll). 
An experimental evaluation of the comparative effects of iso¬ 
caloric diets of carbohydrate, fat, and protein in nephrectomized 
rats was carried out by Masson, Corcoran, and Page (12), taking as 
criteria of benefit blood urea nitrogen levels and survival time. 
They were able to show by these criteria that a carbohydrate diet is 
somewhat more beneficial than a fat diet and that both are far 
superior to a protein diet or to administration of no calories at 
all. These authors also demonstrated prolonged survival of nephrec¬ 
tomized rats administered testosterone or desoxycorticosterone acetate 





Since there has been considerable experimental evidence that 
testosterone, in addition to its androgenic properties, has a potent 
anabolic effect, producing prolonged retention of nitrogen, phos¬ 
phorous, and potassium in the intact animal and human (15, 14-, 15, 
16, IT), it seemed reasonable to assume after Masson's demonstration 
that this anabolic action of testosterone could offer protection 
against cellular breakdown to patients with acute anuric uremia 
even in the face of the associated profound metabolic derangements 
and altered diet which did not exist in the original hormone studies. 
In subsequent years, there has been but little report in the 
literature of the use of testosterone in the therapy of acute renal 
failure with the result expected from the implications of Masson's 
work. A report of 3 cases in the French literature is available which 
demonstrated a decrease in the progress of azotemia in renal shutdown 
treated with 80 mg. of testosterone a day (18). Encouraging reports 
of the use of testosterone in the therapy of chronic renal failure are 
more easily found with the observation that its administration pro¬ 
duces a substantial retention of nitrogen and potassium and a 
decrease in the level of the blood urea nitrogen together with a 
"positive sense of well-being" on the part of the patient (19, 20). 
Merrill (8) and Bull (5) recommend its use in renal failure, acute 
and chronic. 
Hyperkalemia, one of the more important complications of con¬ 
tinuing anuria, has a depressant effect on muscular activity and may 
produce paralysis and cardiac arrest. Kolff (21) has demonstrated 
that administration of insulin with infusion of very large amounts 






of glucose will result in a decrease in the serum potassium over a 
24-hour period. In the anuric individual, it is probable that po¬ 
tassium is induced to move from the extracellular to an intracellu¬ 
lar site. 
There has been considerable discussion concerning protection 
by potassium against digitalis-induced cardiac arrhythmias, as re¬ 
viewed by Lown (22). In digitalis intoxication, any of the salts 
of potassium will abolish manifestations of drug overdose (23, 24). 
In many circles, the reverse proposition is also held to be true: 
that digitalis will counteract the myocardial toxic effects of ex¬ 
cess serum potassium, particularly in the situation of acute renal 
failure. It is difficult to find published documentation of this 
thesis. 
In 1940, Zwemer and Lowenstein (25) reported experiments with 
normal, intact rats, mice, and cats, showing that very high doses 
of cardiac glycosides (strophanthin, ouabain, and digitalin) pre¬ 
viously administered, protected the animals against lethal amounts of 
infused KC1. In another series of experiments, it was observed that 
normal serum potassium could be significantly decreased over a 24- 
hour period after an injection of strophanthin. Apparently, it 
was on thebasis of this evidence that digitalis has been regarded 
as a possible adjunct to the therapy of hyperkalemia in acute renal 
failure. 
In the series of experiments to be reported, we were interested 
in observing the differential protein-sparing effect of varying 
amounts of carbohydrate calories and in re-evaluating the role of 
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testosterone in experimental acute renal failure in the rat. Par¬ 
ticular attention was directed at potassium metabolism, and the 
effect of the cardiac glycosides against hyperkalemia and its 
toxicity in the context of anuria was investigated. 
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MATERIALS AND METHODS 
The animals used vere male albino rats ranging in weight from 
250 to 375 grams. Nephrectomy was performed in two stages, 7 days 
apart, removing the organs through lumbar incisions under ether 
anesthesia. The kidney capsule was stripped before removal to 
avoid damage to the adrenal glands. Until the time of the second 
nephrectomy, the animals were fed ad libitum on regular laboratory 
chow and water. The rats were weighed at the time of each opera¬ 
tion and at 24-hour intervals following the second procedure. 
During each 24-hour period subsequent to the second nephrectomy 
each rat received 10 cc of water by gavage (approximately equiva¬ 
lent to 3 cc per 100 square cm of body surface, (after Masson’s 
method (12)), in two divided doses in which was contained a known 
number of calories in the form of glucose. Tail blood was drawn in 
0.5 cc aliquots for determination of blood urea nitrogen and serum 
potassium at the time of the second operation and at 24-hour inter¬ 
vals thereafter. These measurements were done by the micro¬ 
diffusion analysis of Conway (26) and with the Baird flame photo¬ 
meter, respectively. Each determination was done in duplicate. 
The protocol was divided into three series, each including its 
own set of controls: 
Series I a. Four rats received no calories in 10 cc water. 
b. Four rats received 4 glucose calories (1 gram 
of glucose) in 10 cc water. 
c. Four rats received 10 glucose calories (2.5 gram 
of glucose) in 10 cc water. 
, .. £ . 
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Series II. All rats received 10 glucose calories in 10 cc water. 
a. Fifteen rats received 10 mg. daily of Testosterone 
propionate in peanut oil, intraperitoneally, be¬ 
ginning 2k hours before the second nephrectomy. 
b. Seven rats treated similarly, injected with pea¬ 
nut oil alone. 
Series III. All rats received 10 glucose calories in 10 cc water. 
a. Four rats received no cardiac glycoside. 
b. Six rats injected with 0.25 mg Ouabain intra¬ 
muscularly at the time of the second nephrectomy 
(equivalent to the strophanthin dosage of Zwemer 
(25)), followed by injection of 0.125 mg daily 
thereafter. 
c. Four rats injected with 0.05 mg Digitoxin at the 
time of the second nephrectomy, followed by 0.01 mg 
daily thereafter. 
d. Four rats injected with 0.1 mg Digitoxin at the 
time of the second nephrectomy, followed by 0.02 
mg daily thereafter. 









Fed ad libitum after the first nephrectomy, the rats gained 
10 to 15 per cent of their original weight in the seven day interim 
before the second operation. Animals who did not so thrive were dis¬ 
carded. Twenty-four hours following the second procedure the weights 
were decreased by 10 to 15 per cent and remained stable throughout 
subsequent weighings. 
At the time of the second nephrectomy blood taken for urea ni¬ 
trogen and potassium determinations revealed normal values: 20 to 
30 mg per cent and 4.0 to 5*5 mEq/L respectively. 
All values are summarized ae the mean of each group with the 
standard deviation. Unless otherwise stated below, there was no 
significant difference between the distribution of values of the 
experimental and control groups (p > 0.05). 
Time of survival (in hours after the second nephrectomy) is 
correct to + 4 hours. 
In Series I it will be noted that the rats fed only water 
showed a more rapid progress of azotemia (significant at 24 and 
48 hours after nephrectcmy) than did animals receiving 4 to 10 
glucose calories with their water. The glucose-fed animals survived 
longer than the others. Although it appears that the blood urea 
nitrogen may have been somewhat lower and survival longer in animals 
administered 10 calories than shown by the ones receiving 4, there 
was no statistical difference between the two. In all cases, serum 











In Series II, the progress of the azotemia was less rapid in 
the testosterone treated animals than it was in the control group. 
This is suggestive 24 hours after nephrectomy, and there is a signifi¬ 
cant difference between the two groups at 48 hours. Although there is 
no statistical difference, there is a suggestive prolongation of 
life noted in the testosterone treated rats. Again, there is no 
apparent effect of treatment on serum potassium. 
In Series III, it can be seen that neither serum potassium con¬ 
centration nor survival was influenced by the administration of cardiac 
glycosides. 
Reference to Figure I will reveal that the serum potassium con¬ 
centration at 48 hours is not related to survival time, nor can sur¬ 
vival time be related to weight as illustrated in Figure II. Only 
values of rats receiving 10 calories daily in 10 cc of water are 
plotted. 
. 
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In selecting and preparing rats for experimental uremia, an 
effort was made to employ the healthiest animals (as inferred by 
previous weight gain and normal blood urea nitrogen and serum po¬ 
tassium concentration) under optimal conditions. As pointed out by 
Peters (27) there is an increased breakdown of protein following 
severe disease and trauma which is self-limiting and followed by an 
anabolic phase during which time protein is stored. Brown and 
associates (28, 29) have found that during this anabolic phase 
renewed injury caused relatively less waste of protein and that there 
was an earlier anabolic response to administration of high caloric 
diets. On these grounds, it was decided to perform nephrectomy 
utilizing the two-stage procedure in the expectation that the 
rats would be placed in a metabolically more favorable position 
regarding protein economy. 
In starvation experiments, it will be recalled that Gamble (9) 
demonstrated that 100 grams of glucose per day as the sole source 
of calories will, in the normal 70 Kg human, maximally spare endogen¬ 
ous protein for energy requirements. This conservation is equivalent 
to one half the amount of body protein utilized for energy by the 
fasting individual and is not materially exceeded by increase in the 
glucose administration even up to caloric requirements. Under the 
circumstances of a sub-energy maintenance intake, ingested protein 
is oxidized in support of the energy metabolism and will not contribute 
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Butler, et al. (JO) showed a similar pattern of protein sparing 
in normal humans administered only glucose, but treated with testos¬ 
terone propionate. The administration of JO grams/day of glucose 
resulted in a moderate decrease in nitrogen excretion while the 
administration of 100 grams prompted as great a decrease in the 
urinary nitrogen as did J00 grams. 
The minimum requirement of 100 grams/day of glucose for the 
70 Kg man corresponds to 0.5 grams/day for the 550 gram rat. The 
results obtained after administration of 1 gram and 2.5 grams to 
the rats in the present study showed a leveling off similar to that 
noted by Gamble and Butler in the protein-sparing ability of in¬ 
creasing amounts of glucose and again demonstrated that a salutary 
diminution of protein breakdown with prolongation of life may be 
gained far short of caloric requirements. This has been previously 
observed in nephrectomized rats by Bergman and Drury (3l) who ad¬ 
ministered 1 gram/day of glucose to their animals. Masson (12), 
utilizing a more complex diet of carbohydrates, giving each animal 
50 calories per day, reported a greater difference in blood urea 
nitrogen and survival between these animals and the controls than we 
were able to demonstrate. Since he did not compare diets with vary¬ 
ing caloric values and gives no indication of the state of hydration 
of his control group, it is not feasible to evaluate his data 
quantitatively in the context of our comparative results. 
Although a significant reduction was demonstrated in the daily 
rise of blood urea nitrogen in glucose fed, nephrectomized rats treated 
■ j >v d ] . 
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with testosterone propionate, no influence of the hormone was ob¬ 
served on serum potassium concentration. A suggestive, but not 
statistically significant beneficial effect on survival time was 
also noted in the experimental group. Inasmuch as it has been well 
established that testosterone acts as a powerful stimulus to re¬ 
tention of nitrogen, potassium, and phosphorus, presumably in the 
formation of new tissue, it is interesting to speculate why a more 
marked suppression of the accumulation of protein breakdown products 
was not seen. 
In metabolic balance studies, testosterone given intramuscularly 
in doses of 25 mg/day to normal young men produces a gradual fall in 
the excretion of nitrogen which, after 4-8 days reaches a peak (13). 
West and Tyler (32) administered the same total dose of testosterone 
propionate (162-200 mg) dissolved in human serum albumin, intravenously 
in a single dose to normal men and demonstrated an equivalent maximum 
retention of nitrogen only 24 hours after this dose. Since it was 
noted that smaller doses similarly given produced only slight reten¬ 
tion and that 40 per cent of the large effective dose could be 
accounted for in the urine as 17-ketosteroids in 2 hours, 70 to 80 per 
cent recoverable in 24 hours, it was concluded that the effectiveness 
of the large intravenous dose could not be attributed to a sustained 
high level of hormone in the blood, but that a minimum high initial 
blood level was required for prompt penetration into cells and rapid 
action. Other routes of administration cannot provide as prompt a 
tissue distribution. 
In the present analysis it becomes important to know whether 
testosterone may exert an anti-catabolic action as well as an anabolic 
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effect. The work of Perlman and Cassidy (33) demonstrates in dogs 
that at minimal balance levels of protein, constituting 11.8 per cent 
of the dietary intake, no nitrogen retention could be induced by 
testosterone propionate. From this and earlier work by Kochakian 
and Van der Mark (34), it may be interpreted that protein administra¬ 
tion must contribute between 12 per cent and l8 per cent of the diet 
in order for testosterone to produce a retention of nitrogen. 
Studies by Kenyon and Knowlton (35) demonstrated a similar tendency 
in a normal human adult. If testosterone had an appreciable anti- 
catabolic action, one would expect to observe a decrease in the 
urinary nitrogen excretion in animals maintained on minimal protein 
intake. 
To return to the role of testosterone in the therapy of experi¬ 
mental acute renal failure, it is proposed that effective protection 
against cellular breakdown cannot be expected in this context. 
Firstly, utilizing an intramuscular or intraperitoneal administra¬ 
tion of the poorly soluble depot preparation, it Is possible that 
maximal tissue levels are not realized before the death of the animals, 
roughly 72 hours after nephrectomy and 96 hours after the first in¬ 
jection. A more important factor limiting demonstration of the 
anabolic effect of testosterone is that the animals, of necessity, 
are maintained on a diet devoid of protein, the building block of 
new tissue. Furthermore, if we assume from the inferences of ex¬ 
periments on other animals that testosterone has no appreciable 
anti-catabolic action, then there is no difficulty in understanding 
why the hormone does not reproduce the effects seen in many of the 
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earlier studies on normal individuals, receiving adequately 
balanced diets. 
The experimental data show a slight, although unquestion¬ 
able conservation of protein, as reflected by the lower blood urea 
nitrogen in the treated animals. Evaluated in the light of the 
principles evolved above, it is proposed that although maximal end- 
organ concentration of testosterone may not have been achieved, there 
was some effective tissue penetration in the lifetime of the animals. 
Minimal anabolic effect was observed, and in the absence of exogenous 
sources, must be attributed to action on stored protein as the sub¬ 
strate . 
Albright (36) states that the formation of tissue results in the 
accompaniment of each gram of nitrogen by 3 mEq of potassium. The 
data herein presented neither confirm nor contradict this statement. 
If it is assumed that production of tissue accounts for the difference 
observed between the blood urea nitrogen of the testosterone treated 
animals and the untreated animals at b8 hours after nephrectomy 
(Series II), this difference of 36 mg per cent would theoretically, 
in the 300 gram rat, produce a difference of approximately 1 mEq/L 
in the concentration of potassium between the two groups. This 
xJLde d- 
assumes a uniform distribution ofApotassium in body water (65 per 
cent of body weight). It will be noted that the mean values of 
serum potassium determined at that time are virtually identical. 
However, the standard deviations from the mean of the experimental 
and control groups are quite wide, each more than 1 mEq/L. 
In the last series of experiments, there was no protection 
against early death of the nephrectomized rats with administration 
of cardiac glycosides. It will be recalled that Zwemer and Lowen- 
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stein (25), using intact animals, protected with strophanthin 
against infused, lethal amounts of KC1. 
To explain this paradox, it is important to consider first of 
all that death of the nephrectomized animal is due to more than a 
simple elevation of potassium in the blood. That the mortality is 
associated with a more complex picture and possibly the presence of 
other metabolites and imbalances is illustrated by the fact that there 
was no constant inverse correlation between concentration of serum 
potassium and length of survival after nephrectomy (Figure l). This 
observation is in keeping with the well-known fact that there is seldom 
a predictable relation between measured serum potassium and signs 
of toxicity in the human patient in uremia (21). 
To account for the protecting influence of digitalis in simple 
hyperkalemia, it is noted that the cardiotonic glycosides all con¬ 
tain the cyclopentanoperhydrophenanthren© nucleus in common with the 
steroid hormones, cholesterol and the Vitamins D. At the C17 
position is attached an unsaturated butyrolactone ring in which 
the cardiotonic properties of the various glycosides reside. 
CH?OH f 
HO 
Estradiol Desoxycorticosterone Digitoxigenin 
The ability of the adrenocortical hormones to produce potassium 
diuresis and depletion is common knowledge. It is not difficult to 
imagine that the cardiac glycosides, in ample dose, or their break¬ 
down products, may have a similarity in action to DCA to explain the 
... 
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protection by digitalis observed by Zvemer against administered 
potassium which might have been produced by an increased excretion 
of potassium in the animals so treated. Obviously, nephrectomized 
animals are unable to respond in this way. These authors pointed 
out the similarity of their results to those reported earlier by 
Zwemer and Truszkowski (37) of "the protection against potassium 
poisoning with adrenocortical hormone. 
Lending some support to a steroidal activity of digitalis, 
there have been published several accounts of an estrogen-like 
effect producing gynecomastia, occasionally seen in men chronically 
treated with the drug (38, 39)- However, there are no reports 
available of observations of an adrenocortical activity of digitalis. 
Further inquiry into this interesting possibility must await proper 
balance studies. 




From results of studies on a small series of nephrectomized rats, 
several conclusions were reached. 
The rat like the human, can be induced to spare endogenous pro¬ 
tein by the administration of carbohydrate, in amounts much less than 
actual caloric requirements. 
In experimental acute uremia, only minimal anabolic activity 
can be demonstrated by testosterone propionate. The absence of 
dietary protein mitigates against influences ordinarily producing 
new tissue formation or protein storage. 
Digitalis was shown to have no effect on survival or serum po¬ 
tassium in anuric rats maintained on a minimum oral fluid intake. 
The relation between serum potassium concentration and its toxi¬ 
city in anuria is considered. In light of previous experimental data 
showing protection against 'Uncomplicated potassium toxicity by digitalis, 
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